BiotechTube
Viscus Biologics

Viscus Biologics

San Diego, United States· Est.
viscusbiologics.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.5M

Overview

Viscus Biologics is a private, revenue-generating CDMO and biomaterials company focused on the regenerative medicine and medical device sectors. Its core value proposition is a vertically integrated service model, combining custom ECM biomaterial development with full-spectrum product realization for clients. The company's technology is based on a proprietary decellularization process for porcine tissues, producing a range of ECM form factors. Strategic partnerships, notably with Johnsonville Holdings and its subsidiary Sustainable Swine Resources (SSR), provide a critical supply chain advantage for raw materials.

Regenerative MedicineMedical Devices

Technology Platform

Proprietary decellularization process for porcine tissues to produce acellular extracellular matrix (ECM) biomaterials with intact architecture and bioactive components, supplied in various form factors for regenerative medicine applications.

Funding History

1
Total raised:$2.5M
Seed$2.5M

Opportunities

The growing regenerative medicine market and increased outsourcing by biotechs create strong demand for specialized CDMOs with biomaterials expertise.
The company's strategic raw material supply partnership provides a scalable and reliable foundation for growth.
Participation in industry consortia like ARMI|BioFabUSA offers networking, credibility, and access to cutting-edge collaborative projects.

Risk Factors

Revenue is dependent on the success and timelines of client programs, creating inherent volatility.
The use of animal-derived materials subjects the company to complex and stringent regulatory pathways for every client product.
Competition is intense from both larger CDMOs and other specialized biomaterial firms.

Competitive Landscape

Viscus competes in the specialized ECM biomaterials and niche CDMO space. Key competitors include other ECM-focused companies like ACell and Matricel, as well as broader regenerative medicine CDMOs. Its differentiation lies in the vertical integration of proprietary porcine ECM supply (via SSR) with full product realization services, offering clients a unique 'one-stop-shop' from raw material to finished device.

More companies in Biologics / Biosimilars →More companies in United States →